<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01549145</url>
  </required_header>
  <id_info>
    <org_study_id>EST-01-IL</org_study_id>
    <nct_id>NCT01549145</nct_id>
    <nct_alias>NCT01139554</nct_alias>
  </id_info>
  <brief_title>Sub-chronic Neurostimulation Delivered in the Middle Ear for Tinnitus Suppression</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>EstimME Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EstimME Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to evaluate the safety and efficacy of applying electrical
      stimulation on the promontorium (EPS) for the suppression of tinnitus in a sub-chronic
      stimulation regimen.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy</measure>
    <time_frame>2 months</time_frame>
    <description>Study efficacy evaluations will be based on the analysis of pre and post procedure tinnitus severity characteristics (THI, MML, Pitch matching and VAS values).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>2 months</time_frame>
    <description>Safety evaluations will be based on the observation for the reporting of any adverse events occurring during the study and up to the 30 days follow-up visit Occurrence of adverse events.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Tinnitus</condition>
  <arm_group>
    <arm_group_label>NIMBUS multifunctional stimulator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A Multifunctional Stimulator (Nimbus by Newmedic, Hemodia) for clinical use. The stimulator is also dedicated for Electrical Promontory Stimulation (EPS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nimbus Multifunctional Stimulator</intervention_name>
    <description>A Multifunctional Stimulator (Nimbus by Newmedic, Hemodia) for clinical use. The stimulator is also dedicated for Electrical Promontory Stimulation (EPS)</description>
    <arm_group_label>NIMBUS multifunctional stimulator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Total score on the Handicap Inventory (THI) of at least 40.

          2. Visual scale over 5.

          3. Tinnitus origin is peripheral (related to long term noise exposure, or to a sudden
             exposure to a very loud noise etc.)

          4. Tinnitus is on-going; present for more than 50% of the time over the past 12 months.

          5. Unilateral tinnitus

          6. Tinnitus prevalent at least 12 months.

          7. Willingness to abstain from part taking in other, non-study procedures indicated to
             lessen tinnitus and/or its perception.

          8. Willing and able to refrain from engaging in activities or work involving loud noise
             exposure.

          9. Male or females 18-60 years of age

        Exclusion Criteria:

          1. Prior history of sudden hearing loss and/or fluctuating hearing levels.

          2. Tinnitus prevalent more than 3 years.

          3. History of frequent middle ear infections

          4. Patient under immunosuppressant therapy

          5. Auditory nerve damage.

          6. Vestibular Schwannoma

          7. Cochlear implant.

          8. Pregnant or lactating.

          9. Developmental disability or cognitive impairment that would make it difficult for the
             subject to partake in the clinical study, including adequate comprehension of the
             informed consent form and ability to record the necessary measurements.

         10. Involvement in litigation and/or a worker's compensation claim and/or receiving
             disability benefits related to tinnitus and/or hearing loss.

         11. Not being physically or geographically capable of returning for scheduled follow-up
             visits.

         12. Any physical, psychological, or emotional disorder that would interfere with the
             planned surgical operations

         13. Mentally retarded, developmentally delayed or suffering from organic brain
             dysfunction.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2012</study_first_posted>
  <last_update_submitted>August 28, 2012</last_update_submitted>
  <last_update_submitted_qc>August 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Severe</keyword>
  <keyword>Ongoing</keyword>
  <keyword>Unilateral</keyword>
  <keyword>present for more than 6 months</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

